Chalmers Ventures

What they fund

• Pre-seed — Up to 1 MSEK (approx. €85k) for early-stage spinouts requiring structural capital and venture creation support [3].
• Seed — Up to 5 MSEK (approx. €425k) typically with co-investors to validate business models and reach paying customers [3].
• Growth — Up to 25 MSEK (approx. €2.1M) for companies scaling internationally, requiring active ownership and syndication [3].
• Sector Fit — Deep tech and research-based technologies with global commercial potential, often originating from Chalmers University spinouts [4][3].

Investment thesis

Chalmers Ventures operates an evergreen, research-to-company pipeline that merges venture creation with direct investment to transform breakthrough academic research into globally scalable, impact-driven deep tech companies [1][2]. The firm identifies high-potential university spinouts, actively matches them with entrepreneurial teams, and provides structural capital and hands-on governance from lab to exit [1]. By retaining ownership in an evergreen structure, returns are continuously reinvested to fuel new research and innovation at Chalmers University of Technology [1][2]. The strategy prioritizes technologies with global commercial and impact potential, ensuring that every SEK invested attracts significant external syndication [3].

Credibility: The firm's own website details the 'From Lab to Market' process and the evergreen reinvestment model [4][3].

Value add

Chalmers Ventures provides hands-on venture creation, including tech matching, incubation programs, and active governance throughout the company's lifecycle [4]. The firm leverages a vast network of co-investors to syndicate rounds and attract competent capital [3].

Fit verdict: Ideal for deep tech founders needing operational support, team building, and patient capital aligned with long-term impact.

Founder diligence script:

• How does Chalmers Ventures structure the 'tech matching' process to find the right entrepreneurial team for a research-heavy idea?
• What is the typical timeline from lab identification to a formal investment decision in the 'From Lab to Market' process?
• How does the evergreen model impact the firm's liquidity expectations and exit timeline compared to traditional VC funds?

Portfolio focus

• Structural Batteries & Advanced Materials — Sinonus (energy-storing carbon fiber composites) and Oxeon (carbon fiber for NASA's Ingenuity helicopter) [2].
• Healthtech & Medtech — 1928 Diagnostics (antibiotic resistance), Amferia (innovative plasters), and Atley Solutions (cancer research) [4][5].
• Cleantech & Environmental Tech — Adsorbi (air purification with supermaterials) and Atium (water purification from heavy metals) [4].
• Aviation & Mobility — Avinode (private jet flight management) and Sinonus (EV and drone applications) [2][4].

Notable investments & exits

• No public exits disclosed — The firm's website and available documents do not list specific realised exits or losses, focusing instead on ongoing portfolio development and scaling [1][3].
• Portfolio value tracking — The firm tracks portfolio value and invested capital, but specific exit events and outcomes are not publicly detailed in the provided sources [3].
• Exit strategy focus — The firm pursues a positive exit strategy at what it feels is the right time, focusing resources on companies with the greatest potential [1].

Strategic implications

Chalmers Ventures' evergreen model provides a significant competitive advantage by aligning long-term capital with long-term research impact, reducing the pressure for quick exits common in traditional VC. The firm's deep integration with Chalmers University gives it unparalleled access to high-quality, early-stage deep tech spinouts, creating a proprietary deal flow. The focus on impact and sustainability may attract ESG-focused co-investors, enhancing the firm's ability to syndicate large growth rounds.

Where they could go further

The firm could expand its 'Tech Matching' program to include more international entrepreneurs, reducing the reliance on local Swedish talent for global deep tech ventures. Increasing transparency around portfolio performance and exit outcomes would enhance credibility with external LPs and co-investors. Developing a more structured follow-on investment strategy for Series B and beyond could help portfolio companies scale more effectively without relying solely on external syndication.